News
In October of last year, Millipore—which operates as the CDMO arm of Germany’s Merck KGaA in the U.S. and Canada— unveiled a $76 million investment in its plant in St. Louis, which will add ...
NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, teamed up with ...
NORTHAMPTON, MA / ACCESS Newswire / June 23, 2025 / After captivating students across North America and Europe with access to hands-on science, the Curiosity Cube from the Life Science business of Mer ...
BURLINGTON, Mass. — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced Neoclease as the winner of ...
MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services
Simtra and Merck KGaA's alliance integrates bioconjugation and fill/finish services, streamlining ADC manufacturing and reducing complexity for clients. With 70% of ADCs manufactured by CDMOs and over ...
NORTHAMPTON, MA / ACCESS Newswire / June 25, 2025 / Between September 2024 and April 2025, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, teamed up ...
About the Life Science business of Merck KGaA, Darmstadt, Germany The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26 ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced Neoclease as the winner of the 2025 North ...
June 11, 2025 By: Rachel Klemovitch Assistant Editor Simtra BioPharma Solutions, a CDMO specializing in sterile injectables, has formed a five-year strategic alliance with the Life Science business of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results